Genmab
GMAB
18,03 €
Share price
2.04%
Change (1 day)
-32.25%
Change (1 year)
Categories
Market capitalization of Genmab (GMAB)
Market cap: €11.28 Billion
As of April 2025 Genmab has a market cap of €11.28 Billion. This makes Genmab the world's 1370th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Genmab from 2010 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €11.28 B | -12.55% |
| 2024 | €12.90 B | -31.43% |
| 2023 | €18.81 B | -27.8% |
| 2022 | €26.06 B | 12.71% |
| 2021 | €23.12 B | 6.58% |
| 2020 | €21.69 B | 68.56% |
| 2019 | €12.86 B | 46.82% |
| 2018 | €8.76 B | 4.33% |
| 2017 | €8.40 B | -11.93% |
| 2016 | €9.53 B | 30.36% |
| 2015 | €7.31 B | 165.56% |
| 2014 | €2.75 B | 87.37% |
| 2013 | €1.47 B | 180.41% |
| 2012 | €0.52 B | 131.9% |
| 2011 | €0.22 B | -50.38% |
| 2010 | €0.45 B |
End of Day market cap according to different sources
On Apr 24th, 2025 the market cap of Genmab was reported to be:
